NCT01044576

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis Opening the Window of Therapeutic Opportunity

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 200 (actual)
• Sponsor: Imperial College London · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The primary goal of the research cohort is to facilitate patient access to clinical trials testing new therapeutic interventions, or access to second- line treatments. Secondary objectives of the research cohort study are to obtain detailed clinical phenotyping and immunological analysis of blood samples, aiming to identify and validate biomarkers of disease activity and response to treatment and prognostic markers.

Conditions

• Relapsing-remitting Multiple Sclerosis
• Secondary Progressive Multiple Sclerosis

Timeline

• Start date: 2010-01-01
• Primary completion: 2012-11-01
• Completion: 2012-11-01
• First posted: 2010-01-08
• Last updated: 2021-03-08
• Results posted: 2021-03-08

Locations

1 site across 1 country: United Kingdom